|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 262, Issue 1 E105-E109, Copyright © 1992 by American Physiological Society
ARTICLES |
L. A. Cassis
Division of Pharmacology and Experimental Therapeutics, College of Pharmacy, University of Kentucky, Lexington 40536-0082.
To determine if insulin has the ability to regulate components of the renin-angiotensin system, renin and angiotensinogen mRNA and plasma concentrations were determined in 4-wk streptozotocin (STZ)-diabetic rats. In another group of STZ-diabetic rats, replacement insulin therapy was given over the 4-wk period, and the above parameters were examined. In STZ-diabetic rats, there was a significant regression of white adipose tissue that was accompanied by an increase in the yield of RNA obtained. Changes in white adipose tissue were reversed by insulin replacement therapy in STZ-diabetic rats. There were no changes in brown adipose tissue weight or RNA yield in STZ-diabetic rats. Plasma renin activity (PRA) was significantly decreased in STZ-diabetic rats; however, plasma angiotensinogen concentration was not significantly affected by diabetes. PRA was restored to control levels in STZ-diabetic rats with insulin replacement. Kidney renin mRNA as well as liver, epididymal, and interscapular fat angiotensinogen mRNA were significantly decreased in STZ-diabetic rats. Renin and angiotensinogen mRNA were not significantly different from control in all tissues examined in STZ-diabetic rats with insulin replacement therapy. Results from this study suggest a downregulation of the renin-angiotensin system in 4-wk STZ-diabetic rats at the level of mRNA expression that is restored by replacement therapy with insulin; therefore, insulin may directly or indirectly regulate the renin-angiotensin system.
This article has been cited by other articles:
![]() |
H. Lu, C. M. Boustany-Kari, A. Daugherty, and L. A. Cassis Angiotensin II increases adipose angiotensinogen expression Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1280 - E1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Hakam, A. H. Siddiqui, and T. Hussain Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats Am J Physiol Renal Physiol, February 1, 2006; 290(2): F503 - F508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. PRICE, L. E. PORTER, M. GORDON, N. D. L. FISHER, J. M. F. DE'OLIVEIRA, L. M. B. LAFFEL, D. R. PASSAN, G. H. WILLIAMS, and N. K. HOLLENBERG The Paradox of the Low-Renin State in Diabetic Nephropathy J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2382 - 2391. [Abstract] [Full Text] |
||||
![]() |
J. WAGNER, F. GEHLEN, A. CIECHANOWICZ, and E. RITZ Angiotensin II Receptor Type 1 Gene Expression in Human Glomerulonephritis and Diabetes Mellitus J. Am. Soc. Nephrol., March 1, 1999; 10(3): 545 - 551. [Abstract] [Full Text] |
||||
![]() |
J. H. Pratt, W. T. Ambrosius, D. A. Tewksbury, M. A. Wagner, L. Zhou, and M. P. Hanna Serum Angiotensinogen Concentration in Relation to Gonadal Hormones, Body Size, and Genotype in Growing Young People Hypertension, November 1, 1998; 32(5): 875 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Claycombe, B. H. Jones, M. K. Standridge, Y. Guo, J. T. Chun, J. W. Taylor, and N. Moustaid-Moussa Insulin increases fatty acid synthase gene transcription in human adipocytes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1253 - R1259. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |